Cargando…
Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity
BACKGROUND: The life expectancy of untreated non-small-cell lung cancer (NSCLC) is dismal, while treatment for NSCLC improves survival. The presence of comorbidities is thought to play a significant role in the decision to treat or not treat a given patient. We aim to evaluate the association of com...
Autores principales: | Rios, Jorge, Gosain, Rahul, Goulart, Bernardo HL, Huang, Bin, Oechsli, Margaret N, McDowell, Jaclyn K, Chen, Quan, Tucker, Thomas, Kloecker, Goetz H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789001/ https://www.ncbi.nlm.nih.gov/pubmed/29416376 http://dx.doi.org/10.2147/CMAR.S151935 |
Ejemplares similares
-
Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
por: Bhandari, Shruti, et al.
Publicado: (2021) -
Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond
por: Kanaan, Zeyad, et al.
Publicado: (2015) -
Unlocking the potential of population‐based cancer registries
por: Tucker, Thomas C., et al.
Publicado: (2019) -
Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma
por: SINGH, RAJESH, et al.
Publicado: (2014) -
CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases
por: Mir, Hina, et al.
Publicado: (2015)